Human Papilloma Virus: Clinical Trials

135 trials for Human Papilloma Virus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

69 completed, 25 unknown, 19 recruiting, 10 active not recruiting. 61 Not applicable, 18 Phase 2, 11 Phase 1, 9 Phase 4, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable61Completed 37, Unknown 11, Active not recruiting 5, Recruiting 5, Terminated 2, Not yet recruiting 1
Phase 218Completed 9, Recruiting 4, Terminated 2, Unknown 2, Active not recruiting 1
Phase 111Completed 6, Not yet recruiting 2, Active not recruiting 1, Recruiting 1, Terminated 1
Phase 49Completed 2, Not yet recruiting 2, Recruiting 2, Withdrawn 2, Active not recruiting 1
Phase 34Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1
Early Phase 12Active not recruiting 1, Unknown 1

Follow Human Papilloma Virus: new trials by email Literature Review of Human Papilloma Virus trials Research Report on Human Papilloma Virus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy - Hepatitis B, Human Papilloma Virus
Phase 4Not yet recruitingEunice Dube21402027-01-302026-07-30
Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV
Dose Level 1 ACU-D1 ointment, Dose Level 2 ACU-D1 ointment, Dose Level 3 ACU-D1 ointment - Human Papilloma Virus, Human Immunodeficiency Virus
Phase 1Not yet recruitingEmory University92026-12-012026-08-18
Developing and Implementing HPV SCREENED
HPV Self-collection in the ED - Cervical Cancer Screening, Human Papilloma Virus
Not applicableRecruitingRutgers, The State University of New Jersey1002026-10-152026-10-22
Blood Biomarkers Based Screening for HPV-driven OPC
HPV16-E6 serology and HPV ctDNA - Head and Neck Squamous Cell Carcinoma, Anal Cancer
Not applicableNot yet recruitingUNICANCER100002026-09-012026-05-26
HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV
HPV-CTLs - Human Papilloma Virus
Phase 1 / Phase 2TerminatedShenzhen Geno-Immune Medical Institute1002026-06-012026-08-24
Mobile App-Supported HPV and Breast Cancer Awareness Program
mobile application - Human Papilloma Virus, Breast Cancer
Not applicableCompletedAtaturk University702025-11-022026-03-13
PopSci CHW4CervixHealth
Evalyn® Brush, Copan Floqswab, CHW4CervicalHealth - Cervical Cancer, Hpv
Not applicableRecruitingThomas Jefferson University1202025-10-222026-08-11
Merck IIT: RRP Pembro and Lenvatinib
Lenvatinib, Pembrolizumab - Human Papilloma Virus, Recurrent Respiratory Papillomatosis
Phase 2RecruitingYale University202025-07-182026-07-02
HPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks
Offering opportunistic HPV vaccine during routine sexual health clinic visits - Human Papilloma Virus
RecruitingUniversity of Edinburgh5002025-07-072026-06-09
Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
Lidocaine 1% Injectable Solution - Oropharyngeal Squamous Cell Carcinoma (OPSCCA), Oropharyngeal Cancer
Phase 1RecruitingRyan Carey302025-04-232026-05-12
Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers
Fludarabine, Cyclophosphamide, NEXI-003 T cells - Oropharyngeal Cancer, Human Papilloma Virus
Phase 1Not yet recruitingNexImmune Inc.362025-03-312024-01-16
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
Human papillomavirus (HPV) vaccine, 9-valent - Human Papilloma Virus, Anal Dysplasia
Phase 2RecruitingUniversity of Maryland, Baltimore1202025-03-152026-08-05
Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial
Usual Care, ECA-HPV App with Clinic Notification and Adolescent Functions Disabled, ECA-HPV App with Clinic Notification Function Enabled - Human Papilloma Virus
Not applicableTerminatedTufts Medical Center292024-11-132025-07-15
Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.
GARDASIL®9, Menveo®/Menactra® - Human Papilloma Virus, Hiv
Phase 4Active not recruitingMassachusetts General Hospital7782024-10-142026-01-12
Validation of Vaginal Self-Sampling With the Abbott Multi-Collect Swab for HPV Screening in Women Aged 30 to 64 Years
Abbott Multi-Collect Specimen Collection Swab - Human Papilloma Virus, Human Papilloma Virus Related Cervical Carcinoma
CompletedAML10002024-09-192026-08-17
High Resolution Anuscopy Study
HRA - Human Papilloma Virus, Anal Squamous Cell Carcinoma
RecruitingUniversitair Ziekenhuis Brussel5002024-08-082025-02-19
Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
Gardasil 9 - Human Papilloma Virus
TerminatedUniversity of Alabama at Birmingham342024-08-082026-04-20
Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples
Colli-Pee 20mL device with UCM, Evalyn Brush - Uterine Cervical Neoplasm, Uterine Cervical Dysplasia
Not applicableRecruitingUniversiteit Antwerpen1002024-03-282024-09-19
Prevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence
smears - Human Papilloma Virus, Sexual Assault
UnknownCentre Hospitalier Universitaire Saint Pierre2002024-02-012024-02-13
Screening With Tampons: Evaluating Diagnostic Accuracy and HPV and Assessing Participant Views
DAYE Diagnostic Tampon, Vaginal self-swab, Clinician vaginal swab - Chlamydia, Gonorrhea
Not applicableCompletedAnne's Day Ltd6172024-01-152025-07-31

Showing 20 of 135. Sign in to see all of them.

Narrower conditions

Uterine Cervical Neoplasms (36)  ·  Uterine Cervical Dysplasia (16)  ·  Oropharyngeal Neoplasms (11)  ·  Acquired Immunodeficiency Syndrome (10)  ·  Anus Neoplasms (8)  ·  Papillomavirus Infections (8)  ·  Squamous Cell Carcinoma of Head and Neck (7)  ·  Head and Neck Neoplasms (5)  ·  Squamous Intraepithelial Lesions (5)  ·  Condylomata Acuminata (4)  ·  Recurrence (4)  ·  Recurrent respiratory papillomatosis (4)  ·  Atypical Squamous Cells of the Cervix (3)  ·  Carcinoma, Squamous Cell (3)  ·  Health Education (3)

Broader conditions

Genital Diseases (58)  ·  Urogenital Diseases (58)  ·  Neoplasms (57)  ·  Neoplasms by Site (54)  ·  Female Urogenital Diseases (42)  ·  Female Urogenital Diseases and Pregnancy Complications (42)  ·  Genital Diseases, Female (42)  ·  Uterine Diseases (39)  ·  Uterine Cervical Diseases (38)  ·  Genital Neoplasms, Female (35)  ·  Urogenital Neoplasms (35)  ·  Uterine Neoplasms (35)  ·  Infections (32)  ·  Pathological Conditions, Signs and Symptoms (29)  ·  Communicable Diseases (26)

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (5)  ·  Carboplatin (4)  ·  Cisplatin (4)  ·  Colposcopy (4)  ·  Papillomavirus Vaccines (4)  ·  Fluorouracil (3)  ·  Biopsy (2)  ·  Human Papillomavirus Recombinant Vaccine nonavalent (2)  ·  Paclitaxel (2)  ·  Radiation (2)  ·  Radiotherapy (2)  ·  Radiotherapy, Intensity-Modulated (2)  ·  artemisinin (2)  ·  human papillomavirus vaccine, L1 type 16, 18 (2)  ·  Active Hexose Correlated Compound (1)

Sponsors

Universiteit Antwerpen (5)  ·  Emory University (3)  ·  First Hospital of China Medical University (3)  ·  Johns Hopkins University (3)  ·  National Cancer Institute (NCI) (3)  ·  UNC Lineberger Comprehensive Cancer Center (3)  ·  Antiva Biosciences (2)  ·  Augusta University (2)  ·  Boston Medical Center (2)  ·  George Washington University (2)  ·  Procare Health Iberia S.L. (2)  ·  Universitair Ziekenhuis Brussel (2)  ·  University of Chicago (2)  ·  Uriach Consumer Healthcare (2)  ·  Zagazig University (2)

Countries

United States (62)  ·  Belgium (11)  ·  China (6)  ·  Spain (6)  ·  France (5)  ·  United Kingdom (5)  ·  Canada (4)  ·  Turkey (Türkiye) (4)  ·  Denmark (3)  ·  South Africa (3)  ·  Egypt (2)  ·  El Salvador (2)  ·  Germany (2)  ·  Rwanda (2)  ·  Sweden (2)

Top investigators

Pierre Van Damme, MD, PhD (4)  ·  Alex Vorsters, Ir, PhD (2)  ·  Noel T Brewer, PhD (2)  ·  Severien Van Keer, PhD (2)  ·  Xinghua Gao (2)  ·  Abbey B Berenson, MD, PhD (1)  ·  Adam Donne (1)  ·  Adane Mihret, PhD (1)  ·  Ahinoam Lev Sagie, MD (1)  ·  Ahmad Nofal, MD (1)  ·  Amber D'Souza, PhD (1)  ·  Amy Leader, DrPH, MPH (1)  ·  Andrzej Kulczycki, PhD (1)  ·  Anna-Barbara Moscicki, MD (1)  ·  Ardis L Olson, MD (1)

Results publications

PMID 34462327, PMID 30866981, PMID 31053174, PMID 31369771, PMID 31420362, PMID 32914443, PMID 32953426, PMID 33323462, PMID 33421649, PMID 33743523, PMID 33905482, PMID 34464624, PMID 35488669, PMID 35778065, PMID 35814366, PMID 36008069, PMID 36071389, PMID 36113531, PMID 36113532, PMID 36239625, PMID 36353194, PMID 36460537, PMID 36804149, PMID 37032449, PMID 37207682, PMID 37410084, PMID 37500273, PMID 37585432, PMID 37933546, PMID 38015219, PMID 38285445, PMID 38294704, PMID 38320488, PMID 38365419, PMID 39362749, PMID 39445512, PMID 39890232, PMID 39934916, PMID 39950735, PMID 39981930, PMID 40048190, PMID 40402400, PMID 40483901, PMID 40877387, PMID 41067140, PMID 41276263, PMID 41318410, PMID 41419735, PMID 41820928, PMID 42032732

NIH funding

P01CA250989 (3), K01AI106961 (1), P30CA023108 (1), P30CA046934 (1), P30CA177558 (1), R01CA229324 (1), R01CA240375 (1), R01NR020154 (1), R21CA238170 (1), R35DE026631 (1), U54CA254568 (1)